# Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

> **NCT02656017** · PHASE2 · COMPLETED · sponsor: **Kyongtae Ty Bae, M.D., Ph.D.** · enrollment: 97 (actual)

## Conditions studied

- Polycystic Kidney, Autosomal Dominant

## Interventions

- **DRUG:** Metformin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02656017
- **Lead sponsor:** Kyongtae Ty Bae, M.D., Ph.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-27
- **Primary completion:** 2020-12-07
- **Final completion:** 2020-12-07
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2022-08-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02656017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02656017, "Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02656017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*